Subscribe
shutterstock_264466154brian-a-jackson
Brian A Jackson / Shutterstock.com
15 May 2020Big PharmaBeatriz San Martin

Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

At the end of April the Court of Justice of the European Union (CJEU) delivered its judgment in Case C-650/17 Royalty Pharma Collection Trust.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?
20 May 2020   Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.
Europe
Unitary SPC should follow new patent system: EC official
11 June 2020   The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.
Big Pharma
UKIPO cancels SPC extension at owner’s request
16 June 2020   The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?
20 May 2020   Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.
Europe
Unitary SPC should follow new patent system: EC official
11 June 2020   The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.
Big Pharma
UKIPO cancels SPC extension at owner’s request
16 June 2020   The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More on this story

Americas
Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?
20 May 2020   Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.
Europe
Unitary SPC should follow new patent system: EC official
11 June 2020   The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.
Big Pharma
UKIPO cancels SPC extension at owner’s request
16 June 2020   The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More features

China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
Teva faces $500m fine for antitrust breaches over MS drug
Pfizer infringed haemophilia therapy patent, says court
Big Pharma counsel embrace AI but data and legal risks loom
MSN scores win in battle with Novartis over heart drug generic
HR, lobbying and business strategy…all in a day’s work for today’s counsel